(Q24567496)

primary sclerosing cholangitis

inferred from title

1 reference

3

Emmanouil Sinakos

0 references

author name string

Christos Tsaitas

series ordinal

1

0 references

Anysia Semertzidou

series ordinal

2

0 references

language of work or name

English

0 references

publication date

27 April 2014

0 references

published in

World Journal of Hepatology

1 reference

Colorectal cancer and dysplasia in inflammatory bowel disease

volume

6

0 references

issue

4

0 references

page(s)

178-87

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Cancer in inflammatory bowel disease

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

New IBD genetics: common pathways with other diseases.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Chemoprevention and screening in primary sclerosing cholangitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Colonoscopy, tumors, and inflammatory bowel disease - new diagnostic methods

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Genetics of liver disease: immunogenetics and disease pathogenesis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

SCLEROSING CHOLANGITIS; REVIEW OF RECENT CASE REPORTS AND ASSOCIATED DISEASES AND FOUR NEW CASES.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Primary sclerosing cholangitis; review and report of six cases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Crohn's disease and colorectal cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Role of bile acids in colorectal carcinogenesis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Relationship of inflammatory bowel disease and primary sclerosing cholangitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Increase by deoxycholic acid of the colonic nuclear damage induced by known carcinogens in C57BL/6J mice.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study

30 May 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Increased Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in First-Degree Relatives of Patients With Primary Sclerosing Cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Colonic mucosal proliferation is related to serum deoxycholic acid levels.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009473

Chromosomal and Microsatellite Instability of Adenocarcinomas and Dysplastic Lesions (DALM) in Ulcerative Colitis

28 November 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I4.178

Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Bile acid receptors in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Crohn's disease and ulcerative colitis are associated with the DNA repair gene MLH1

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Sclerosing cholangitis in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Inflammatory bowel disease and hereditary nonpolyposis colorectal cancer: is there a genetic link?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Primary sclerosing cholangitis: a long-term follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Primary sclerosing cholangitis: a heterogenous disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Increased serum deoxycholic acid levels in men with colorectal adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

European evidence-based Consensus on the management of ulcerative colitis: Special situations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Inflammatory bowel disease and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Increased prevalence of primary sclerosing cholangitis among first-degree relatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

SCLEROSING CHOLANGITIS. ASSOCIATION WITH REGIONAL ENTERITIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Cancer risk in patients with inflammatory bowel disease: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

The fate of low grade dysplasia in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Clinicopathologic features of the syndrome of primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Cancer risk in extensive ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

Bile acid-induced activation of activator protein-1 requires both extracellular signal-regulated kinase and protein kinase C signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020

The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24799986

12 December 2020